Amicus Therapeutics, Inc. stockholders approved the acquisition by BioMarin Pharmaceutical Inc. during a virtual meeting on March 3, 2026, with approximately 74.79% of shares present.
AI Assistant
AMICUS THERAPEUTICS INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.